Search Results - Manik Kuvalekar
- Showing 1 - 6 results of 6
-
1
Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay by Kiriakos Koukoulias, Penelope G. Papayanni, Julia Jones, Manik Kuvalekar, Ayumi Watanabe, Yovana Velazquez, Sarah Gilmore, Anastasia Papadopoulou, Ann M. Leen, Spyridoula Vasileiou
Published in Frontiers in Immunology (2023-12-01)Get full text
Article -
2
Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections by Spyridoula Vasileiou, Anne M. Turney, Manik Kuvalekar, Shivani S. Mukhi, Ayumi Watanabe, Premal Lulla, Carlos A. Ramos, Swati Naik, Juan F. Vera, Ifigeneia Tzannou, Ann M. Leen
Published in Haematologica (2020-01-01)Get full text
Article -
3
Longitudinal analysis of the evolution of cellular immunity to SARS-CoV-2 induced by infection and vaccination by Spyridoula Vasileiou, Manik Kuvalekar, Yovana Velazquez, Ayumi Watanabe, Mansi Narula, Aster G. Workineh, Matthew French-Kim, Alejandro Torres Chavez, Sarah Gilmore, Cliona M. Rooney, Ann M. Leen
Published in Haematologica (2022-11-01)Get full text
Article -
4
“Mini” bank of only 8 donors supplies CMV-directed T cells to diverse recipients by Ifigeneia Tzannou, Ayumi Watanabe, Swati Naik, Rachel Daum, Manik Kuvalekar, Kathryn S. Leung, Caridad Martinez, Ghadir Sasa, Mengfen Wu, Adrian P. Gee, Robert A. Krance, Stephen Gottschalk, Helen E. Heslop, Bilal Omer
Published in Blood Advances (2019-09-01)Get full text
Article -
5
Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients by Spyridoula Vasileiou, LaQuisa Hill, Manik Kuvalekar, Aster G. Workineh, Ayumi Watanabe, Yovana Velazquez, Suhasini Lulla, Kimberly Mooney, Natalia Lapteva, Bambi J. Grilley, Helen E. Heslop, Cliona M. Rooney, Malcolm K. Brenner, Todd N. Eagar, George Carrum, Kevin A. Grimes, Ann M. Leen, Premal Lulla
Published in Haematologica (2022-11-01)Get full text
Article -
6
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer by Valentina Hoyos, Spyridoula Vasileiou, Manik Kuvalekar, Ayumi Watanabe, Ifigeneia Tzannou, Yovana Velazquez, Matthew French-Kim, Wingchi Leung, Suhasini Lulla, Catherine Robertson, Claudette Foreman, Tao Wang, Shaun Bulsara, Natalia Lapteva, Bambi Grilley, Matthew Ellis, Charles Kent Osborne, Angela Coscio, Julie Nangia, Helen E. Heslop, Cliona M. Rooney, Juan F. Vera, Premal Lulla, Mothaffar Rimawi, Ann M. Leen
Published in Therapeutic Advances in Medical Oncology (2022-07-01)Get full text
Article
